bullish
Mankind Pharma Placement - Well Flagged, past Deals Have Done Well but Its Expensive
257 Views25 Mar 2024 21:42
ChrysCap is looking to raise around US$295m via selling a 2.8% stake in Mankind Pharma. In this note, we talk about the deal dynamics.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
- Mankind Pharma Placement - Well Flagged, past Deals Have Done Well but Its Expensive25 Mar 2024
- Mankind Pharma Placement - Its Expensive, but at Least It’s High Quality12 Dec 2023
- Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release31 Oct 2023
- Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag08 May 2023
x